Same Indication

Pembrolizumab vs Warfarin

Pembrolizumab vs Warfarin: Overview

This comparison examines the pharmacological differences between Pembrolizumab and Warfarin.

Mechanism of Action

Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.

Warfarin: Inhibits vitamin K epoxide reductase complex.

Pharmacokinetics

Half-life: Pembrolizumab — 26 days; Warfarin — 20-60 hours.

Chemical Properties

Molecular Formula: Warfarin — C19H16O4.

Molecular Weight: Warfarin — 308.3280 g/mol.

Type: Pembrolizumab — Antibody; Warfarin — Small molecule.